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Objectives The primary aim of this systematic review is to objectively evaluate the test performance characteristics of
three-dimensional echocardiography (3DE) in measuring left ventricular (LV) volumes and ejection fraction (EF).
Background Despite its growing use in clinical laboratories, the accuracy of 3DE has not been studied on a large scale. It is
unclear if this technology offers an advantage over traditional two-dimensional (2D) methods.
Methods We searched for studies that compared LV volumes and EF measured by 3DE and cardiac magnetic resonance
(CMR) imaging. A subset of those also compared standard 2D methods with CMR. We used meta-analyses to
determine the overall bias and limits of agreement of LV end-diastolic volume (EDV), end-systolic volume (ESV),
and EF measured by 3DE and 2D echocardiography (2DE).
Results Twenty-three studies (1,638 echocardiograms) were included. The pooled biases  2 SDs for 3DE were 19.1 
34.2 ml, 10.1  29.7 ml, and  0.6  11.8% for EDV, ESV, and EF, respectively. Nine studies also included
data from 2DE, where the pooled biases were 48.2  55.9 ml, 27.7  45.7 ml, and 0.1  13.9% for EDV,
ESV, and EF, respectively. In this subset, the difference in bias between 3DE and 2D volumes was statistically
significant (p  0.01 for both EDV and ESV). The difference in variance was statistically significant (p  0.001)
for all 3 measurements.
Conclusions Three-dimensional echocardiography underestimates volumes and has wide limits of agreement, but compared
with traditional 2D methods in these carefully performed studies, 3DE is more accurate for volumes and more pre-
cise in all 3 measurements. (J Am Coll Cardiol 2012;59:1799–808) © 2012 by the American College of Cardiology
Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.01.037The assessment of left ventricular (LV) volume and ejection
fraction (EF) is vital to the practice of cardiology. These
measures are used to inform prognosis in most cardiac
patient populations, determine treatment decisions for a
variety of therapies, and function as eligibility criteria in
many clinical trials (1–5). Despite their importance, there is
no consensus on the best method to routinely measure EF
and volumes.
Two-dimensional echocardiography (2DE) is the most
ubiquitous tool for assessing LV size and systolic function.
Measurement of EF is the most common reason for
referring a patient for an echocardiogram (6). This test is
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accepted January 31, 2012.noninvasive, portable, inexpensive, radiation free, and quick.
It does not, however, provide reliable, reproducible, and
accurate measures of EF or volumes (7). Traditionally, 2DE
has used the method of disks to calculate LV volumes based
on areas in only 2 imaging planes (6). This method is subject
to errors due to foreshortening, poor endocardial definition,
narrow echocardiographic windows, and assumptions about
LV shape.
Because it is able to image the entire heart in multiple
planes and provides excellent endocardial definition, cardiac
magnetic resonance (CMR) imaging has been used as the
gold standard for measuring LV volumes and EF (8).
Nevertheless, the expense, limited availability, and incom-
patibility with metallic hardware make CMR impractical for
widespread clinical use.
Three-dimensional echocardiography (3DE) uses re-
cently developed matrix array echocardiographic probes to
image the entire heart in8 beats/min. As opposed to older
3D methods, “live” 3D datasets provide volumes with
minimal post-processing. Some echocardiographic labora-
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nology for routine care and
charge for it using a new billable
Current Procedural Terminology
code for 3DE (9). Yet, it is still
unclear if 3DE offers an advan-
tage over 2DE, and, if so, in
which patients and with which
specific techniques.
In this era when new technol-
ogy, especially in imaging, has
escalated medical costs, advances
like 3DE should be thoroughly
evaluated before recommending
their large-scale use (10). We,
therefore, undertook this system-
atic review of the 3DE published
reports to evaluate its perfor-
mance compared with CMR and its utility over traditional
2D methods in calculating EF and volumes.
Methods
Search selection. To determine the test performance char-
acteristics of 3DE in measuring LV volumes and EF, we
included all studies that compared 3DE with CMR in adult
patients. Most used Pearson’s correlations between CMR
and 3DE-derived LV end-diastolic volume (EDV), end-
systolic volume (ESV), and EF. As correlation coefficients
alone are misleading, we required that acceptable studies
contain a Bland-Altman (BA) analysis of agreement for at
least 1 of the 3 measurements (11). Although not required
for inclusion, many studies also compared 3DE with tradi-
tional 2D methods and provided BA analysis on inter- and
intraobserver variability. We excluded studies that only
investigated freehand (rather than live or “real-time”) 3DE,
did not include CMR as a gold standard, only included
children, only evaluated the right (rather than the left)
ventricle, only reported on LV mass (rather than volumes or
EF), or were only published in abstract form. In addition,
we excluded early studies done with probes or software that
are not currently commercially available.
Search strategy. We searched 7 electronic information
sources for studies published between January 1, 1990 and
September 14, 2011: MEDLINE, Cardiosource Clinical
Trials, the Cochrane Central Register of Controlled Trials,
the Cochrane Health Technology Assessment Database,
the International Standard Randomized Controlled Trial
Number Register, National Institutes of Health Clinical-
Trials.gov, and UpToDate Online. We used variations and
combinations of the following search terms: three-
dimensional echocardiography, real-time three-dimensional
echocardiography, heart ventricles, and cardiac magnetic
resonance imaging. We limited the search to humans,
adults, and English language. In addition to database
Abbreviations
and Acronyms
2D  two-dimensional
2DE  two-dimensional
echocardiography
3D  three-dimensional
3DE  three-dimensional
echocardiography
BA  Bland-Altman
CMR  cardiac magnetic
resonance
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
LV  left ventricularsearches, we reviewed the references of included studies andother relevant review articles to obtain a comprehensive list
of included studies (Table 1). The database searches were
performed twice and reviewed by 2 authors (J.L.D., E.E.S.).
Data abstraction. The quantitative data collected were the
differences in EDV, ESV, and EF calculations determined
by 3DE and CMR and expressed as the BA bias and limits
of agreement. Where reported, we also recorded the BA
differences for 2DE with CMR as well as intra- and
interobserver analyses. To assess the applicability of 3DE in
a general population of patients referred for echocardiogra-
phy, we were particularly interested in the types of patients
included in each study. Thus, we collected the distributions
of disease types, sex, average ages, and the average sizes of
the ventricles studied. To assess the general feasibility of
3DE, we noted in each study the method of patient
selection and number of patients excluded due to poor
image quality. We also logged the type of platform and
methods used to obtain volumes.
Statistical analysis. Baseline patient characteristics for
each study were re-weighted according to the number of
patients in the sample and used to compute a pooled
estimate of average age and EDV (expressed as mean 
D). Our analysis included summary estimates of BA
tatistics to assess agreement of the 2 competing procedures.
e used BA analytical methods because they are more
nformative than Pearson’s correlation coefficients in com-
aring methods where the main goal is to assess accuracy
ather than to determine if 2 competing procedures have
ssociated outcomes (11). BA methods only provide esti-
ates in lieu of statistical tests and level of significance like
ore traditional clinical trials. Like the BA methodology,
ur synthesis strategy included weighted summary statistics.
hus, for pooled estimates of 3DE and 2DE performance
ompared with CMR, we simply computed appropriate
ummary statistics (weighted sums and sums of squares)
cross individual studies, which were combined to produce
ooled estimates of BA biases and limits of agreement for
ach of the 3 measurements. We found that the reported
A limits of agreement were inconsistently computed across
he studies (which may have used 1, 1.96, or 2 SDs of the
eported bias). For the purposes of our meta-analysis, we
onverted each study’s reported estimates and expressed our
imits of agreement as bias 2 SDs. For intraobserver and
nterobserver variability, we included studies that calculated
he mean differences between the observations divided by
heir average and reported them as mean difference with or
ithout limits of agreement. Again, these average differ-
nces were pooled to compute an overall measure of the
bserver difference and limits of agreement (also expressed
s 2 SDs). Significant differences between 3DE and 2DE
iases were tested using the paired t test. To determine
significant differences in the variances, we used Levene’s test
for the homogeneity of variances (35). A p value 0.05 was
considered statistically significant. SAS version 9.2 (SAS
Institute, Cary, North Carolina) was used for all calculations
and statistical testing.
rdiac m
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Search results and patient population. Electronic and man-
ual searches from reference lists produced 189 citations, of
which 88 were excluded as irrelevant based on title and
keywords. The remaining 101 were reviewed in detail by
reading the abstract or paper in full. Of these, 78 were
excluded for a priori defined criteria (Fig. 1), leaving 23
included articles, comprising 1,174 patients (Table 1) (12–34).
Nine of these reported results on separate patient groups or did
the 3DE analysis twice using different methods, resulting in 34
distinct protocols with 1,638 separate 3DE analyses. Each of
these substudies was treated as a separate data source in this
Included Studies and Patient CharacteristicsTable 1 Included Studies and Patient Characteristics
First Author (Ref. #) N Age (yrs)
Mean EDV by
CMR (ml)
MRI to
Echo Time
Jenkins et al. (12) 50 63 10 207 79 N/A
Soliman et al. (13) 24 51 12 213 63 2 h
Pouleur et al. (14) 83 54 19 187 70 1 day
Mor-Avi et al. (15) 92 57 16 N/A 1 day
Chukwu et al. (16) 69 65 5.5 171 47 24 h
Bicudo et al. (17) 20 32 15 135 28 N/A
Qi et al. (18) 58 59 139 59 1 day
Jenkins et al. (19) 30 66 7 168 54 1 week
van den Bosch et al. (20) 29 31 9 155 38 2 h
Sugeng et al. (21) 31 60 15 N/A 1 day
Jenkins et al. (22) 110 63 11 180 55 N/A
Jacobs et al. (23) 50 58 19 N/A N/A
Chan et al. (24) 30 62 9 179 56 12 days
Gutiérrez-Chico et al. (25) 35 61 17 N/A 1 day
Jenkins et al. (26) 50 64 8 172 53 N/A
Nikitin et al. (27) 64 65 12 195 72 N/A
Soliman et al. (28) 41 56 11 182 54 1 day
Soliman et al. (29) 53 57 11 175 51 1 day
Kuhl et al. (30) 24 65 12 N/A 1 day
Caiani et al. (31) 20 58 17 164 64 1 day
Marsan et al. (32) 52 62 10 288 87 1 day
Macron et al. (33) 50 59 18 161 59 1 day
Chang et al. (34) 109 53 14 137 1 day
3D  three-dimensional; ASD  atrial septal defect; CAD  coronary artery disease; CMR  ca
cardiomyopathy; LV left ventricular; N/A not available; NICM nonischemic cardiomyopathy; Pmeta-analysis (Table 2). These patients had a wide spectrum ofcardiac abnormalities. Across studies, the following disease
states were represented: 10% normal controls, 45% coronary
artery disease, 9% dilated cardiomyopathy, 4% systolic dysfunc-
tion (not otherwise characterized), 4% valve disease, 8% hy-
pertrophic cardiomyopathy, 3% congenital heart disease, 1.4%
hypertension, and 16% other or not reported. The majority
(72%) were men. The weighted age was 58.0 13.7 years, and
EDV by CMR was 184.9  61.8 ml.
Excluded patients. All studies excluded patients who were
not in sinus rhythm at the time of their echocardiograms.
Due to incompatibility with CMR, patients with internal
pacemakers or defibrillators or severe claustrophobia were
atient Selection and Number Excluded
Due to Poor Images Diseases Studied
ecutive 0 All with WMAs
d to excellent images” N/A 29% normal, 42% ICM, 29% NICM
ecutive 0 24% normal, 40% CAD,
36% valve disease
ded cardiac surgery patients 0 N/A
ded if 2 unseen segments 1 51% normal, 49% ICM
ecutive 0 100% HCM all with normal EF
ecutive 0 24% normal, 40% CAD,
12% NICM, 5% valve disease,
5% ASD/VSD
ded for poor images or
cquisitions
7 All with WMAs
ded for poor images and
spiratory artifact
3 Congenital heart disease with
septal flattening
quate endocardial visualization” N/A 29% normal, 45% CAD,
23% NICM, 1% HCM
ded due to inability to measure 3D 7 89% WMA, 11% with
global dysfunction
quate endocardial visualization” 8 48% CAD, 36% NICM, 8% valve
disease, 4% coarctation,
4% right atrial mass
ecutive 0 All with prior MI, altered LV shape,
or WMA
ecutive 0 23% ICM, 26% HCM, 17% valve
disease, 11% myocarditis,
17% NICM, 6% congenital
ded if “technically inadequate” 7 14% normal, 82% with WMA,
4% HTN
d acoustic windows” 16 16% normal, 63% ICM or NICM,
22% HT /HFN EF
ded if 2 unseen segments N/A 15% ICM, 22% NICM,
22% noncompaction, 41% HCM
ded if 2 unseen segments N/A 17% ICM, 24% NICM, 21%
noncompaction, 38% HCM
ded if 2 unseen segments N/A 42% normal, 2% NICM, 42% ICM
ded only poor images N/A 5% normal, 35% CAD, 45% NICM,
10% HCM, 5% PAH
ded for 2 unseen segments 5 ICM with aneurysm referred for
surgery
ded for poor images 16 42% CAD, 10% valve disease,
6% NICM, 6% HCM, 36% other
ded for poor endocardial definition 18 38% normal, 32% CAD,
19% HCM, 7% NICM, 6% other
agnetic resonance; HCM  hypertrophic cardiomyopathy, HTN  hypertension; ICM  ischemic
ulmonary arterial hypertension; VSD ventricular septal defect; WMAwall motion abnormality.P
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Meta-Analysis of 3D Echocardiography May 15, 2012:1799–808image quality and excluded patients with suboptimal images
(Table 1). Among studies that reported the number of
exclusions, a total of 88 patients (7.5%) were excluded; 6
studies (representing 123 patients) did not report on the
number of excluded patients. One study used contrast
imaging and included only those with poor images (31).
Five studies recruited a variety of patients consecutively
without exclusions for image quality (12,14,15,18,25). Of
these, Jenkins et al. (12) reported that 20% of patients had
technically difficult images; Pouleur et al. (14) noted that
16%, 35%, 32%, and 17% had excellent, good, moderate,
and fair images, respectively.
3DE methods used in the selected studies. All studies
except 2 used a Philips Medical Systems 2 to 4 MHz 3D
matrix array transducer (Andover, Massachusetts). One
study used the General Electric 2.5 MHz transducer (Hor-
ton, Norway) (33), and one used the Siemens Medical
Systems Acuson SC2000 transducer (Mountain View, Cal-
ifornia) (34). For analysis of the 3D datasets, there were 2
general methods used to calculate volumes (Fig. 2). The first
was manual tracing of equally spaced individual long- or
short-axis slices at end-systole and end-diastole. To corre-
spond with CMR standards, papillary muscles and trabecu-
lations were treated as part of the LV cavity. The number of
slices was chosen by the operator and ranged from 2 to 12;
however, according to studies that specifically assessed the
quality of data based on number of planes, a minimum of 8
Figure 1 Published Report Selection
This flow sheet describes how the 23 included studies were selected for the
meta-analysis. 2D two-dimensional; 3D  three-dimensional; CMR  cardiac
magnetic resonance.planes were needed to achieve the best results (16,25). The rsecond method required the user to identify 3 to 5 points at
the apex and mitral annuls in the 2- and 4-chamber
end-diastolic and end-systolic views. From these points, the
software used automated border-detection to create a 3D
endocardial shell of the entire ventricle from which volumes
were calculated. There were 4 principal software platforms
(QLab, Philips Medical Systems, Andover, Massachusetts;
TomTec Imaging systems, Munich, Germany; Echopak,
General Electric Vingmed Ultrasound, Horton, Norway;
and Argus, Siemens Medical Solutions, Mountain View,
California). Our selection of studies used a variety of slices
versus mesh techniques on all 4 platforms (Table 2). Four
studies were done to specifically compare the slices versus
mesh techniques (16,22,29,30). Only 2 studies used contrast
for LV opacification (12,31). As reported by Jenkins et al.
(22), the average time to trace 12 slices was 10.5  1 min,
hereas 4  0.3 minutes were required to identify the
oints for the mesh technique. This compared with 1.5 
.45 min to trace 2D images for the method of discs.
DE and CMR agreement results. Table 2 and Figure 3
how the BA bias and limits of agreement for EDV, ESV,
nd EF from the 34 studies. The overall pooled bias  2
Ds were 19.1  34.2 ml, 10.1  29.7 ml, and 0.6 
1.8% for EDV, ESV, and EF, respectively. To better
pproximate a typical population seen in an echocardio-
raphic laboratory, we performed a subanalysis that in-
luded the 6 substudies (368 echocardiograms) that did not
xclude patients for image quality. In this case, the BA
iases 2 SDs were 28.8  38 ml, 17.9  34 ml, and
.3  15.5% for EDV, ESV, and EF, respectively. As the
uicker mesh-based technique is also more likely to be used
outinely in echocardiographic laboratories, we also per-
ormed a subanalysis with the 4 studies (512 echocardio-
rams) that compared the mesh versus slices methods
16,19,29,30). The pooled BA biases 2 SDs for the mesh
echnique compared with CMR were 22.7  29 ml,
12.1  25 ml, and 0.4  9.1%; for slices, they were
12.6  25 ml, 8.1  21 ml, and 1.0  9.0% for EDV,
SV, and EF, respectively.
DE and 2DE agreement results. Nine articles (14
ubstudies) reported comparisons of both 3DE and 2DE
ith CMR (12,16,17,19,22,23,25,26,32). Table 3 and
igure 4 show the BA estimates for these studies. For 2DE,
he pooled BA biases  2 SDs were 48.2  55.9 ml,
27.7  45.7 ml, and 0.1  13.9% for EDV, ESV, and
F, respectively. The 3DE pooled BA biases 2 SDs in
hose same studies were 15.7 31.0 ml,9.6 25.8 ml,
nd 0.0  9.2% for EDV, ESV, and EF, respectively. The
ifferences in biases between 3DE and 2DE were statisti-
ally significant for volumetric measurements (p  0.01 for
oth EDV and ESV), but not for EF (p  0.42). The
ifference in width of the variances was statistically
ignificant for all 3 measurements (p  0.001).
nterobserver and intraobserver variability. The pooled
esults for EDV from the 21 substudies (541 echocardio-
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and intraobserver variability are shown in Figure 5
(12,13,15,19,21,23,24,26 –30,33,34). Of these, 4 studies
(110 echocardiograms) also reported results for 2DE
(12,19,23,26). For 3DE, mean percent differences
(mean  2 SDs) were 5.8  12.54 and 3.9  8.5, for
interobserver and intraobserver variability, respectively.
For 2DE, the mean percent differences were 4.8  21.1
and 0.2  19.6. The difference in width of the variances
Comparison of Three-Dimensional Echocardiography Versus MagneTable 2 Comparison of Three-Dimensional Echocardiography Ve
First Author (Ref. #)
Substudy
R Values
EDV ESV EF
Jenkins et al. (12)
Noncontrast 1a N/A N/A N/A
Contrast 1b N/A N/A N/A
Soliman et al. (13) 2 0.98 0.98 0.97
Pouleur et al. (14) 3 0.97 0.98 0.94
Mor-Avi et al. (15) 4 0.91 0.93 0.81
Chukwu et al. (16)
Normals 8-plane 5a 0.99 0.95 0.79
Normals contours 5b 0.99 0.95 0.84
MI 8-plane 5c 0.97 0.97 0.90
MI contours 5d 0.97 0.97 0.90
Bicudo et al. (17) 6 0.94 0.95 0.83
Qi et al. (18) 7 0.92 0.94 0.92
Jenkins et al. (19) 8 0.89 0.92 0.92
Van den Bosch et al. (20) 9 0.97 0.98 0.94
Sugeng et al. (21) 10 0.94 0.85 0.87
Jenkins et al. (22)
On-line 11a 0.78 0.86 0.64
Off-line 11b 0.86 0.91 0.81
Jacobs et al. (23) 12 0.96 0.97 0.93
Chan et al. (24) 13 0.90 0.94 N/A
Gutierrez-Chico et al. (25) 14 0.99 0.99 0.98
Jenkins et al. (26) 15 N/A N/A N/A
Nikitin et al. (27) 16 0.98 0.98 0.94
Soliman et al. (28)
TomTec 17a 0.99 0.99 0.98
Qlab 17b 0.99 0.98 0.97
Soliman et al. (29)
Contours 18a 0.99 0.99 0.98
Multiplane 18b 0.96 0.98 0.95
Kuhl et al. (30)
Manual 19a 0.99 0.99 0.99
Contours 19b 0.98 0.98 0.98
Caiani et al. (31)
Dual-triggering 20a 0.95 0.96 0.77
Continuous imaging 20b 0.89 0.93 0.76
Marsan et al. (32) 21 0.97 0.98 0.97
Macron et al. (33)
1-beat 22a 0.92 0.93 0.85
2-beat 22b 0.94 0.96 0.92
4-beat 22c 0.93 0.95 0.88
Chang et al. (34) 23 0.91 0.94 0.91
*Reported values are rounded to nearest milliliter.
EDV  end-diastolic volume; EF  ejection fraction; ESV  end-systolic volume; MI  myocardetween 3DE and 2DE was statistically significant pp  0.0001) for both interobserver and intraobserver
ariability.
iscussion
nder controlled study settings in patients with adequate
mage quality, 3DE offers better accuracy and precision in
easuring LV volumes and better precision in measuring LV
F compared with 2DE. Although 3DE shows promise in
sonance ImagingMagnetic Resonance Imaging
Bland-Altman (Mean  2 SDs)* Software/
No. of Slices
vs. MeshEDV (m) ESV (m) EF (%)
15 36 9 24 0 6 TomTec/12
6 28 3 20 0 6
7 20 4 8 0 6 Qlab/mesh
20 31 12 31 1 11 Qlab/mesh
67 46 41 46 3 22 Qlab/mesh
1 10 4 11 2 8 TomTec/8
1 6 2 10 2 7 TomTec/mesh
7 35 8 33 1 14 TomTec/8
5 33 4 31 0 14 TomTec/mesh
4 16 0 10 2 11 Qlab/8
22 46 15 40 5 20 TomTec/8
15 31 8 26 1 7 TomTec/12
3 12 1 10 1 7 TomTec/8
5 52 6 52 0 8 TomTec/mesh
44 35 21 28 2 10 Qlab/mesh
15 28 10 22 1 8 TomTec/12
14 34 7 32 1 13 Qlab/mesh
10 53 1 38 N/A TomTec/12
13 34 10 25 N/A TomTec/8
4 29 3 18 0 7 TomTec/mesh
7 28 3 22 1 10 TomTec/mesh
9 9 5 10 0 5 TomTec/mesh
16 13 9 14 1 6 Qlab/mesh
10 9 5 10 1 5 TomTec/mesh
24 19 11 17 1 7 TomTec/8
1 17 0 11 0 5 TomTec/8
14 38 13 41 1 9 TomTec/mesh
14 41 5 33 4 22 Qlab/mesh
23 59 15 41 0 22
22 40 20 41 1 5 Qlab/mesh
21 50 3 44 5 16 GE/Mesh
17 42 9 32 1 12
15 46 12 34 3 14
41 37 8 33 8 13 Siemens/Mesh
ction; N/A  not available.tic Rersusroviding the accessibility of echocardiography and the multi-
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Meta-Analysis of 3D Echocardiography May 15, 2012:1799–808planar imaging of CMR, this nascent technology still has
limited spatial and temporal resolution compared with CMR
as evidenced by clinically significant biases and limits of
agreement.
How good is 3DE? From individual studies and summary
results, it is clear that 3DE, like 2DE, consistently under-
estimates LV volumes (but not EF). More importantly,
there is substantial variability in 3DE calculations, such that
to achieve 95% confidence intervals of true values, one
would have to allow for34 ml for EDV,30 ml for ESV,
and 12% for EF, numbers that would change manage-
ment for many patients. Furthermore, these results repre-
sent images selected for higher quality, and consequently
underestimate the expected variability of routine practice.
For example, an analysis of those studies that accepted all
3D datasets, regardless of image quality, increased the 95%
confidence interval to 38 ml for EDV, 34 ml for ESV,
and 15% for EF.
Which patient populations or methods alter the perfor-
mance of 3DE? Although 3DE does not make assump-
tions about the LV shape, it fares worse in sicker patients
with large ventricles, as seen in the study by Chukwo et al.
(16), who reported results on controls separately from those
with myocardial infarcts. Very large ventricles may not fit
within the scanning sector allotted by the probe (32,34).
Figure 2 Examples of Three-Dimensional Echocardiographic An
Volumes can be obtained from three-dimensional echocardiographic (3DE) dataset
end-diastole and combined to obtain volumes (3 traced slices are shown in A to D
identified on the 4- and 2-chamber views (E to H).With an average EDV of 195 ml, our pooled patient vpopulation is one with significant LV remodeling, which
may account, in part, for the wide confidence interval we
found. LV contrast may improve these results; however, in
the study by Caiani et al. (who only studied patients with
poor images), there was still a large confidence interval (31),
nd Jenkins et al. showed only a minimal clinical benefit
ith LV opacification (12). As described in the preceding
ext, there were 2 very different methods of obtaining
olumes from the 3D datasets. As the mesh technique
nvolves substantially less analysis time compared with
racing slices, it is more likely to be used routinely.
lthough some studies that directly compared the 2
ethods reported better results with tracing slices
16,22), others found that the quicker mesh technique
as more accurate (29,30). Our pooled analysis of the 4
tudies demonstrated little difference in the bias and
ariances between the mesh and slices methods, which
ay validate the quicker mesh technique. Only 1 study
irectly compared 2 separate vendors and found that the
olumes (but not EF) were more accurate in one vendor
28). This study was small and limited to a single center,
o more information might be needed before concluding
hat one platform is superior to the others.
oes 3DE offer an advantage over 2DE? Despite its
imitations, 3DE may be superior to 2D techniques. For
Using Mesh and Slices
of 2 methods. With the first, equally spaced slices are traced in end-systole and
second method uses automated software to generate a 3D mesh from pointsalysis
s by 1
). Theolumes, 3DE under-represents true values about 50% less
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with 2DE. However, more clinical decisions are based on
EF. With EF, there is no difference in the bias between
3DE and 2DE, and the difference in the variance is modest
(4.7%). The benefit of 3DE can be appreciated by
evaluating the intraobserver and interobserver variability,
where 3DE demonstrates much lower variance on both
tests. Low observer variability is particularly important in a
real-world echocardiographic laboratories, with a variety of
readers and sonographers and for patients undergoing serial
examinations to determine clinical worsening.
Strengths and limitations of this meta-analysis. Our
pooled patient sample included a large number of patients
with a wide variety of cardiac diseases. Although we did
include a few studies that were limited to specific patient
groups (17,20,32), most recruited consecutive patients rep-
resenting the spectrum of patients seen in everyday practice.
To ascertain the overall bias of 3DE as seen in Figure 3, we
combined all the included studies, regardless of technique
and platform. We did this to demonstrate the overall bias
and variability of the technology as it performs with the
variety of methods used among different clinical and re-
search laboratories. We recognize, however, that technique
Figure 3 Three-Dimensional Echocardiography Versus Cardiac M
The absolute Bland-Altman difference between 3DE and CMR, expressed as bi
End-diastolic volume (EDV), end-systolic volume (ESV), and ejection fraction (EFand software may matter, which is why we also conducted asubanalysis on those studies that included both the mesh
and slices methods. Many studies reported the analysis
separately for the different techniques, and we chose to
consider these substudies as individual data sources. Al-
though this strategy means that some, but not all, patients
were represented twice, it allows the variety of 3D methods
to be included. The disadvantage of this approach is that it
gives more weight to some patient groups; however, there
were subgroup analysis in enough studies, most of which
had a variety of patients, that this approach did not
significantly change the patient mix. As the aim of this
meta-analysis was to evaluate 3DE performance and not
patient characteristics, it was more important to include all
the different 3DE analyses. We also demanded that 3DE be
compared with CMR for determination of “true” values.
We realize that CMR itself is not perfect, because it also has
errors related to border-detection and controversy on the
inclusion of basal LV planes. Despite these potential sources
of error, CMR is most often used as the gold standard, both
clinically and in research studies. As with any meta-analysis,
ours could also have reported bias, because only those
studies showing positive results for 3DE might have been
published. However, funnel plot analysis of our citations
etic Resonance
SDs for each substudy. The overall pooled results are shown at the bottom.
shown in A, B, and C, respectively. Abbreviations as in Figures 1 and 2.agn
as 2
) aredemonstrated no publication bias (36).
ilable.
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Three-dimensional echocardiography underestimates true
LV volumes and EF and has a substantial degree of
Figure 4 3-Versus 2-Dimensional Echocardiography
Comparison of the Bland-Altman differences (bias 2 SDs) of 3DE compared with
both methods. The overall pooled results are shown at the bottom. EDV, ESV, and
Comparison of Three- Versus Two-Dimensional EchocardiographyTable 3 Comparison of Three- Versus Two-Dimensional Echocar
First Author (Ref. #)
Substudy N
3D Echocardiogra
R -Values Bla
EDV EDS EF EDV (ml)
Jenkins et al. (12)
Non-contrast 1a 50 N/A N/A N/A 15 36
Contrast 1b 50 N/A N/A N/A 6 28
Chukwu et al. (16)
Normals 8-plane 5a 35 0.99 0.95 0.79 1 10
Normals contours 5b 35 0.99 0.95 0.84 1 6
MI 8-plane 5c 34 0.97 0.97 0.90 7 35
MI contours 5d 34 0.97 0.97 0.90 5 33
Bicudo et al. (17) 6 20 0.94 0.95 0.83 4 16
Jenkins et al. (19) 8 30 0.89 0.92 0.92 15 31
Jenkins et al. (22)
On-line 11a 110 0.78 0.86 0.64 44 35
Off-line 11b 110 0.86 0.91 0.81 15 28
Jacobs et al. (23) 12 50 0.96 0.97 0.93 14 34
Gutierrez-Chico et al. (25) 14 35 0.99 0.99 0.98 13 34
Jenkins et al. (26) 15 50 N/A N/A N/A 4 29
Marsan et al. (32) 21 52 0.97 0.98 0.97 22 40
*Rounded to nearest milliliter.
EDV  end-diastolic volume; EF  ejection fraction; ESV  end-systolic volume; N/A  not avavariance, especially in patients with poor images or large
ventricles. In these patient groups, or when the results are
critical and contradict other clinical data, a degree of
versus that of 2D echocardiography in the 12 substudies that reported on
e shown in A, B, and C, respectively. Abbreviations as in Figures 1 and 3.
aphy
2D Echocardiography
man* R-Values Bland-Altman*
ml) EF (%) EDV ESV EF EDV (ml) ESV (ml) EF (%)
24 0 6 N/A N/A N/A 41 42 22 36 2 8
20 0 6 N/A N/A N/A 18 38 8 32 2 8
11 2 8 0.50 0.86 0.23 38 51 25 26 9 16
10 2 7 0.50 0.86 0.23 38 51 25 26 9 16
33 1 14 0.79 0.86 0.86 58 81 46 73 5 18
31 0 14 0.79 0.86 0.86 58 81 46 73 5 18
10 2 11 0.89 0.88 0.75 1 23 0 14 1 14
26 1 7 0.72 0.79 0.65 57 40 26 33 5 12
28 2 10 0.71 0.8 0.61 70 39 34 33 3 11
22 1 8 0.68 0.78 0.70 70 39 34 33 3 11
32 1 13 0.89 0.92 0.86 23 58 15 48 0.8 19
25 N/A 0.78 0.86 0.92 25 132 21 107 3 18
18 0 7 N/A N/A N/A 54 33 28 28 1 13
40 1 5 0.94 0.95 0.96 41 49 33 45 1 5CMR
EF ardiogr
phy
nd-Alt
ESV (
9
3
4
2
8
4
0
8
21
10
7
10
3
20
1807JACC Vol. 59, No. 20, 2012 Dorosz et al.
May 15, 2012:1799–808 Meta-Analysis of 3D Echocardiographyskepticism is warranted. With these caveats in mind, 3DE
offers an advantage over 2DE in providing better accuracy,
precision, and reproducibility for volume measurements.
The advantage in measuring EF, however, is limited to a
modest increase in precision.
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